Decagon Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Decagon Asset Management’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Buy	1,091,327 +88,900	+9%	+$947K	2.23%	11
2026 Q1	$10.6M	Buy	1,002,427 +326,790	+48%	+$3.48M	2.75%	10
2025 Q4	$7.15M	Buy	675,637 +31,316	+5%	+$331K	2.75%	11
2025 Q3	$6.77M	Buy	644,321 +26,305	+4%	+$275K	3.42%	11
2025 Q2	$6.46M	Sell	618,016 -98,930	-14%	-$1.03M	4.21%	9
2025 Q1	$7.33M	Buy	716,946 +7,016	+1%	+$70.4K	5.26%	8
2024 Q4	$7.07M	Buy	+709,930	New	+$7.08M	3.22%	14

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Decagon Asset Management's OACC Position: Q2 2026 in Review

Decagon Asset Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 8.9% in Q2 2026, buying an estimated $947K and bringing the position to 1,091,327 shares worth $11.7M. The position accounts for 2.23% of the portfolio, ranked #11.

Decagon Asset Management first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

Decagon Asset Management held 1,091,327 shares of Oaktree Acquisition Corp III Life Sciences worth $11.7M as of Q2 2026.
Decagon Asset Management bought 88,900 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $947K.
Oaktree Acquisition Corp III Life Sciences made up 2.23% of Decagon Asset Management's portfolio in Q2 2026, its #11 holding.
Decagon Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Decagon Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.